
British medical device company Niox Group (NIOX.L) has announced the termination of its sale process following the withdrawal of interest from Keensight Capital. The Paris-based private equity firm had proposed acquiring Niox for £22.4 million ($29.1 million), offering 81 pence per share, an increase from its earlier bid of 78 pence. The deal, however, has now been scrapped due to deteriorating macroeconomic conditions, the company said on Friday.
Keensight’s decision to back out comes amid growing economic uncertainty driven by escalating global trade tensions. The ongoing trade war, intensified by sweeping tariffs from the U.S. under President Donald Trump’s administration, has shaken global markets and raised fears of a looming recession. The Bank of England also issued a warning this week, highlighting the UK’s vulnerability as an open economy with a significant financial sector.
In March, Niox had indicated that it was in talks with other potential buyers but expressed a preference for Keensight’s proposal, subject to a formal offer. With the latest development, the company has not provided updates on any alternative bids, leaving its future direction unclear amidst broader economic headwinds.
Pic Courtesy: google/ images are subject to copyright